LAL-Deficiency
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Lysosomal Acid Lipase (LAL) Deficiency Registry (NCT01633489) | Alexion Pharmaceuticals, Inc. | 2013-05-30 |
| Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of SBC-102 (Sebelipase Alfa) in Adult Subjects With Lysosomal Acid Lipase Deficiency (NCT01488097) | Alexion Pharmaceuticals, Inc. | 2011-12-12 |
| Safety, Tolerability and Pharmacokinetics of SBC-102 (Sebelipase Alfa) in Adult Participants With Lysosomal Acid Lipase Deficiency (NCT01307098) | Alexion Pharmaceuticals, Inc. | 2011-04-25 |
Track LAL-Deficiency automatically
Every clearance here is in the API, with alerts when new ones post.